The Pathologist / Issues / 2026 / April / Diagnosis DelayedThe Case for Faster Companion Diagnostic Delivery
Oncology Genetics and epigenetics Liquid biopsy Screening and monitoring

Diagnosis: Delayed – The Case for Faster Companion Diagnostic Delivery

From approvals and reimbursement to in-house testing and tissue stewardship - Jane Li discusses the barriers to precision diagnostics, and the route through them

By Helen Bristow 04/02/2026 Interview 7 min read

Share

Clinical Scorecard: Diagnosis: Delayed – The Case for Faster Companion Diagnostic Delivery

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with specific disease biology requiring targeted therapies.
Care Setting

Key Highlights

  • Highlight the need for education and training for healthcare providers to improve adoption.

Guideline-Based Recommendations

Diagnosis

    Management

    • Integrate biomarker testing into clinical pathways and multidisciplinary discussions, including specific strategies for implementation.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Standard treatments may be less effective without proper biomarker testing, leading to suboptimal patient outcomes.

        Clinical Best Practices

        • Include ongoing education and training for laboratory staff to enhance usability.

        Related Resources & Content

          About the Author(s)

          Helen Bristow

          Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.

          More Articles by Helen Bristow

          Explore More in Pathology

          Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

          Recommended